BIIB092 in Primary Tauopathies: CBS, nfvPPA, sMAPT, and TES

NCT03658135 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

22

Enrollment

OTHER

Sponsor class

Stopped BIIB092 program discontinued

Conditions

Primary Tauopathies
Corticobasal Degeneration Syndrome
Frontotemporal Lobar Degeneration With Tau Inclusions
MAPT Mutation Carriers, Symptomatic
Traumatic Encephalopathy Syndrome
Nonfluent Aphasia, Progressive

Interventions

DRUG: BIIB092
OTHER: Placebo

Sponsor

University of California, San Francisco